Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Chanez

Showing results (201-210 of 238) with videos related to

Pageof 24
Sort By:
The New England Journal of Medicine|September 13, 2017
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary DiseaseIan D Pavord, Pascal Chanez, Gerard J Criner, et al.
The Lancet. Respiratory Medicine|November 29, 2025
Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER): a multicentre, single-arm, phase 3b trialDavid J Jackson, Njira L Lugogo, Mark Gurnell, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 4, 2013
Small airways diseases, excluding asthma and COPD: an overviewPierre-Régis Burgel, Anne Bergeron, Jacques de Blic, et al.
BMJ Open|July 3, 2020
Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus studyCarey Meredith Suehs, Maéva Zysman, Cécile Chenivesse, et al.
Thorax|April 9, 2013
Detection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR studyMaciej Kupczyk, Shushila Haque, Peter J Sterk, et al.
ERJ Open Research|April 23, 2024
Severe asthma care trajectories: the French RAMSES cohortJeanne-Marie Perotin, Lisa Gauquelin, Nicolas Just, et al.
Science (New York, N.Y.)|May 25, 2019
Protein crystallization promotes type 2 immunity and is reversible by antibody treatmentEmma K Persson, Kenneth Verstraete, Ines Heyndrickx, et al.
The European Respiratory Journal|August 31, 2019
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questionsArnaud Bourdin, Leif Bjermer, Christopher Brightling, et al.
Allergy|April 3, 2026
Adipokines in Obese Asthma: A Complex Relationship Influenced More by Sex, Weight, and Oral Steroid Treatment Than Disease SeverityLars I Andersson, Maciej Kupczyk, Barbro Dahlén, et al.
American Journal of Respiratory and Critical Care Medicine|January 13, 2009
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthmaSally E Wenzel, Peter J Barnes, Eugene R Bleecker, et al.
Pageof 24

Showing results (201-210 of 238) with videos related to

Sort By:
Pageof 24
The New England Journal of Medicine|September 13, 2017
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary DiseaseIan D Pavord, Pascal Chanez, Gerard J Criner, et al.
The Lancet. Respiratory Medicine|November 29, 2025
Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER): a multicentre, single-arm, phase 3b trialDavid J Jackson, Njira L Lugogo, Mark Gurnell, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 4, 2013
Small airways diseases, excluding asthma and COPD: an overviewPierre-Régis Burgel, Anne Bergeron, Jacques de Blic, et al.
BMJ Open|July 3, 2020
Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus studyCarey Meredith Suehs, Maéva Zysman, Cécile Chenivesse, et al.
Thorax|April 9, 2013
Detection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR studyMaciej Kupczyk, Shushila Haque, Peter J Sterk, et al.
ERJ Open Research|April 23, 2024
Severe asthma care trajectories: the French RAMSES cohortJeanne-Marie Perotin, Lisa Gauquelin, Nicolas Just, et al.
Science (New York, N.Y.)|May 25, 2019
Protein crystallization promotes type 2 immunity and is reversible by antibody treatmentEmma K Persson, Kenneth Verstraete, Ines Heyndrickx, et al.
The European Respiratory Journal|August 31, 2019
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questionsArnaud Bourdin, Leif Bjermer, Christopher Brightling, et al.
Allergy|April 3, 2026
Adipokines in Obese Asthma: A Complex Relationship Influenced More by Sex, Weight, and Oral Steroid Treatment Than Disease SeverityLars I Andersson, Maciej Kupczyk, Barbro Dahlén, et al.
American Journal of Respiratory and Critical Care Medicine|January 13, 2009
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthmaSally E Wenzel, Peter J Barnes, Eugene R Bleecker, et al.
Pageof 24